Author's posts
OhioHealth explores partnership with local hospital
Columbus-based OhioHealth signed a nonbinding letter of intent with Lancaster, Ohio-based Fairfield Medical Center on Sept. 6.
California hospital uses AI to pinpoint aneurysm location
MarinHealth Medical Center is pioneering the use of an AI-powered tool to detect the exact location of an aneurysm, CBS News reported Sept. 9.
University foundation sells former Michigan hospital for $2.5M
The Northern Michigan University Foundation has sold the former Marquette (Mich.) Hospital site to Veridea Group, a design and development management firm, for $2.5 million.
Washington psych hospitals cut back wait times
Washington state’s behavioral health hospitals have reduced admitting time for mental health patients from jail to its facility, The Seattle Times reported Sept. 10.
Illinois hospital accused of sharing patient information with advertisers
Rushville, Ill.-based Sarah D. Culbertson Memorial Hospital is being accused of sharing patients’ information with third parties, including Google, Microsoft and Facebook, the Journal-Courier reported Sept. 10.
Mount Sinai's strategy for implementing TEFCA
As the demand for interoperability persists, health systems nationwide are turning to the Trusted Exchange Framework and Common Agreement to set new standards for interconnectedness and quality of care.
Top 10 AI-ready cities
San Francisco is the most artificial intelligence-ready city of 2024, according to AI market research firm Avantis.
Pennsylvania to pay $4.5 million over 3 months to keep Steward hospital afloat
Dallas-based Steward Health Care filed a Sept. 10 stipulation that Pennsylvania will provide $1.5 million to the for-profit health system’s Sharon (Pa.) Regional Medical Center for three months to keep it from closing.
AbbVie sues BeiGene over alleged trade secret theft
AbbVie has filed a lawsuit against BeiGene, alleging the biotechnology company of stealing trade secrets to develop a competing cancer therapy.
Gene therapy shows promise in early childhood blindness
In a phase 1/2 trial, researchers tested ATSN-101, a gene therapy for Leber congenital amaurosis 1, a rare genetic disorder that typically causes blindness in early childhood.
